Goodbody Health Inc. - Goodbody Health opens first clinic in Canada
RNS Number : 0545C
Goodbody Health Inc.
18 February 2022
 

18 February 2022

Goodbody Health Inc.
("Goodbody Health", or the "Company")

 

Goodbody Health opens first clinic in Canada

Goodbody Health (AQSE: GDBY) is pleased to announce that, following its successful rollout of Goodbody testing clinics in the UK, which undertake Blood and Covid PCR testing, it has signed the lease for its first clinic premises in Vancouver, Canada. The clinic is situated in the Burrard Health Centre - a nine storey health-care oriented office building positioned directly across from St. Paul's Hospital. The building is home to numerous doctors, therapists, medical practitioners and other personal service professionals alike and so it is considered an ideal location for the Company to research future opportunities in Canada and roll out the clinic success of the UK.

 

Geremy Thomas, Executive Chairman, said: "I am delighted to have taken Goodbody clinics across the Atlantic to Canada. I am sure the success Goodbody clinics have had to date in the UK will continue in Canada as well."

 

For further information:

Marc Howells

Chief Executive Officer

Goodbody Health Inc.

+44 (0) 20 7971 1255

enquiries@goodbodyhealth.com

 www.goodbodyhealth.com

Anne Tew

Chief Financial Officer

Goodbody Health Inc.

+44 (0) 20 7971 1255

enquiries@goodbodyhealth.com

 www.goodbodyhealth.com

 

 

 

AQSE Corporate Adviser

Arden Partners plc

Antonio Bossi / George Morgan

+ 44 (0) 20 7614 5900 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXQDLFFLLLZBBZ ]]>